跳至主要内容
临床试验/NCT04934865
NCT04934865已完成不适用

Real Life Prospective Multicentric Study Evaluating the Clinical and Organisational Impact of Moovcare® Lung Connected Medical Device in Lung Cancer Patients : REAL-MOOV-LUNG

Institut Curie29 个研究点 分布在 1 个国家目标入组 240 人开始时间: 2021年10月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
240
试验地点
29
主要终点
Proportion of patients.

研究概览

简要总结

Evaluation of patient's proportion, whose management care has been modified at least once and specially by Moovcare® Lung application at 12 and 24 months.

详细描述

Primary objective of the study:

The primary objective is a clinical one and is to evaluate the proportion of patients, whose management care has been modified at least once and specially by Moovcare® Lung application at 12 and 24 months.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient with lung cancer at any diagnostic stage and histology.
  • Patient willing to use the follow-up setting with Moovcare® Lung apps.
  • Age ≥ 18 years.
  • Patient received anti-cancer treatment (surgery, chemotherapy, radiation (stereotaxy or not) or radio-chemotherapy association ended less than 12 weeks (Cohort 1 post-treatment); or during maintenance treatment or consolidation by chemotherapy or targeted therapy, or by immunotherapy initiated less than 12 weeks (Cohort 2 during treatment).
  • Imaging tumor evaluation less than 12 weeks showing disease control (response or stability according to RECIST 1.1 criteria).
  • Patient with symptomatic score on Moovcare® Lung apps less than
  • Patient (or relatives) with internet access, a personnal e-mail box and a smartphone.
  • Patient with social security affiliation.
  • Signed informed consent form.

排除标准

  • Patient with progression after the first evaluation of initial treatment.
  • Pregnancy and breast-feeding.
  • Patient under tutorship or guardianship.
  • Dementia, mental alteration or psychiatric pathology influencing patient consent procedure and/or protocol observance and study follow-up.
  • Patient enable to protocol follow-up for psychological, social, familial or geographical reasons.

结局指标

主要结局

Proportion of patients.

时间窗: 12 months

Proportion of patients whose care management was modified at least once and specifically by Moovcare® Lung application at 12 months.

次要结局

  • Clinical aspects : Duration of unscheduled hospitalizations.(24 months)
  • Clinical aspects : Duration of overall hospitalizations.(24 months)
  • Organizational aspects : Time for each investigating center(24 months)
  • Clinical aspects : Number of unscheduled hospitalizations.(24 months)
  • Clinical aspects : date of consultation.(24 months)
  • Clinical aspects : Number of overall hospitalizations.(24 months)
  • Clinical aspects : Overall survival over the entire follow-up.(24 months)
  • Clinical aspects : Quality of life.(Every 3 months until 24 months)
  • Organizational aspects : number of stakeholders(24 months)
  • Organizational aspects : Patient satisfaction.(3, 6, 12, 18 and 24 months of use of the application)
  • Organizational aspects : Satisfaction of the care teams at 6 months follow-up.(6 months follow-up)
  • Organizational aspects : Patient compliance.(24 months)
  • Organizational aspects : all secondary outcome measures(12 months of follow-up)
  • Organizational aspects : Functioning and processing of alerts :(24 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (29)

Loading locations...

相似试验